Company Profile | November 9, 2000

Disetronic Medical Systems, Inc

Source: Disetronic Medical Systems, Inc
Capitalizing on the same Swiss engineering that made Disetronic the number one choice of insulin pumps in Europe, we entered the U.S. market with the launch of the H-TRON, which set new standards for control and dependability.

In the ten years that have followed, Disetronic has grown into the second largest provider of insulin pumps in the US, and has led the way in introducing innovations. Since offering the first waterproof pump, Disetronic has continually been the leader in pump and diabetes management development.

Among our newest developments are Diaport, the first percutaneous insulin delivery system. Currently in clinical trials, Diaport will more closely simulate first pass insulin delivery and result in quicker, more efficient insulin reaction times. Also in development is Adicol, a closed loop system that will monitor your blood glucose levels and adjust your insulin pump delivery as needed. For more information on Adicol, visit www.adicol.org.

Looking to the future, Disetronic sees a day when a cure for diabetes will be perfected and readily accessible. Until that day arrives however, we are committed to assisting you to live the best life possible by empowering you with the means to control your diabetes.